Company profile: Xlife Sciences
1.1 - Company Overview
Company description
- Provider of development and commercialization of early-stage life sciences research from universities and research institutions, bridging R&D to healthcare markets. Offers technology platforms, biotechnologies and therapies addressing unmet medical needs, medical technologies, artificial intelligence in life sciences, and digital health projects to enhance healthcare and life quality.
Products and services
- Biotechnologies/Therapies: Engineers clinical-grade biotechnologies and therapies targeting high unmet medical needs to improve life quality, progressing early-stage research toward tangible patient applications
- Medical Technology (Health Technology): Develops healthcare-grade medical technologies enhancing care delivery, translating early-stage innovations from research institutions into practical tools that improve healthcare solutions and patient outcomes
- Technology Platforms: Architects modular life science platforms that bridge university and institutional research to healthcare markets, advancing early-stage projects into commercially viable healthcare products and systems
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Xlife Sciences
Telo Genomics
HQ: Canada
Website
- Description: Provider of telomere-based platforms for biopsies and related technologies in oncology and neurological diseases. Offerings include TeloView, which quantifies genomic instability by measuring the 3D structure and spatial organization of telomeres to assess disease aggressiveness and treatment response, and TeloView SMM, a molecular assay identifying high-risk Smouldering Multiple Myeloma patients for treatment intervention decisions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Telo Genomics company profile →
LumaCyte
HQ: United States
Website
- Description: Provider of label-free single-cell analysis solutions that accelerate medical discoveries, including Radiance, an instrument measuring cellular response using optical and fluidic forces; Laser Force Cytology technology; and software suites Illuminate for control/data analysis and ReportR for automated cloud reporting.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LumaCyte company profile →
Kumovis
HQ: Germany
Website
- Description: Provider of medical technology, developing a 3D printer with clean room integration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kumovis company profile →
Comecer
HQ: Italy
Website
- Description: Provider of protection technologies in nuclear medicine, isolation, and nuclear power plant equipment, and of screening systems for special applications serving hospitals, universities, industrial groups, and research organizations. Products include aseptic processing and containment systems, a Terbium-161 production line, the IRIS radiopharmaceutical injection system, THERABED protected admission management, ISP radioactive waste management, and dose calibrators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Comecer company profile →
Atomic Alchemy
HQ: United States
Website
- Description: Provider of radioisotopes for medical, research, exploration, and industrial use, aiming to establish a reliable domestic supply in the U.S. for medical radioisotopes such as molybdenum-99, in a market that currently lacks a dedicated domestic supplier and relies on university research reactors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Atomic Alchemy company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Xlife Sciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Xlife Sciences
2.2 - Growth funds investing in similar companies to Xlife Sciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Xlife Sciences
4.2 - Public trading comparable groups for Xlife Sciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →